http://www.advfn.com/nasdaq/rss.asp?symbol=SLXP Salix Company Newsfeed en Mon, 30 Jul 2012 09:21:52 EDT Mon, 30 Jul 2012 09:21:52 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=53639889&headline=u-s-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=53639889&headline=u-s-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Monday's session are Acura Pharmaceuticals Inc. (ACUR), Shaw Group Inc. (SHAW) and Trina Solar Ltd. (TSL). </p> <p> Acura said Pfizer Inc. (PFE) has terminated the license to three development-stage products using... Mon, 30 Jul 2012 09:21:52 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=50490787&headline=us-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=50490787&headline=us-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies whose shares are expected to actively trade in Tuesday's session are General Mills Inc. (GIS), AT&amp;T Inc. (T) and Navistar International Corp.'s (NAV). </p> <p> General Mills's fiscal second-quarter earnings fell 28% as higher costs continued to outpace... Tue, 20 Dec 2011 09:18:02 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=48762013&headline=correct-progenics-pharmaceuticals-reports-2q-results http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=48762013&headline=correct-progenics-pharmaceuticals-reports-2q-results <div class='newsbody'><p> (Headlines that ran between 8 a.m. and 8:03 a.m. EDT mistakenly referred to the company as Salix Pharmaceuticals instead of Progenics Pharmaceuticals. Salix reported earnings Monday afternoon.) </p> </div> Tue, 09 Aug 2011 11:14:12 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=46780022&headline=salix-to-seek-fda-meeting-to-discuss-expanded-xifaxan-use http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=46780022&headline=salix-to-seek-fda-meeting-to-discuss-expanded-xifaxan-use <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Salix Pharmaceuticals Ltd. (SLXP) received a letter from Food and Drug Administration, as expected, saying its Xifaxan tablets aren't ready to be approved as a treatment for non-constipation irritable bowel syndrome. </p> <p> The company plans to... Tue, 08 Mar 2011 08:12:23 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=46610396&headline=correct-salix-expects-fda-not-ready-to-approve-xifaxan-indication http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=46610396&headline=correct-salix-expects-fda-not-ready-to-approve-xifaxan-indication <div class='newsbody'><p> ("Salix Expects FDA Not Ready To Approve Xifaxan Indication," published at 7:18 a.m. EST, misstated Wednesday's closing stock price. A corrected version follows.) </p> <pre> DOW JONES NEWSWIRES </pre> <p> Salix Pharmaceuticals Ltd. (SLXP) said a Wednesday night phone call led... Thu, 24 Feb 2011 11:02:35 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=46605605&headline=salix-expects-fda-not-ready-to-approve-xifaxan-indication http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=46605605&headline=salix-expects-fda-not-ready-to-approve-xifaxan-indication <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Salix Pharmaceuticals Ltd. (SLXP) said a Wednesday night phone call led it to believe regulators are not yet ready to approve its drug Xifaxan as a treatment for non-constipation irritable bowel syndrome. </p> <p> The gastrointestinal-focused... Thu, 24 Feb 2011 07:48:43 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=42187271&headline=fda-warns-salix-on-ad-promotional-material-for-drug http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=42187271&headline=fda-warns-salix-on-ad-promotional-material-for-drug <div class='newsbody'><p> By Jennifer Corbett Dooren </p> <p> Of DOW JONES NEWSWIRES </p> <p> WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration warned Salix Pharmaceuticals, Ltd. (SLXP) about an advertisement and promotional material involving a drug used to treat gastroesophageal reflux... Tue, 30 Mar 2010 10:37:47 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=42113816&headline=fda-oks-salix-pharmas-drug-rifaximin-for-liver-condition http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SLXP&article=42113816&headline=fda-oks-salix-pharmas-drug-rifaximin-for-liver-condition <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> The Food and Drug Administration approved Salix Pharmaceuticals Ltd.'s (SLXP) drug rifaximin to treat hepatic encephalopathy, a condition caused by the buildup of toxic substances in the body that impairs brain function. </p> <p> Salix's shares... Wed, 24 Mar 2010 19:22:16 EDT